HER2 insertion YVMA mutant lung cancer: Long natural history and response to afatinib. [electronic resource]
Producer: 20161013Description: 617-9 p. digitalISSN:- 1872-8332
- Afatinib
- Antineoplastic Agents -- therapeutic use
- Humans
- Immunohistochemistry
- Lung Neoplasms -- diagnosis
- Male
- Middle Aged
- Mutagenesis, Insertional
- Protein Kinase Inhibitors -- therapeutic use
- Quinazolines -- therapeutic use
- Receptor, ErbB-2 -- antagonists & inhibitors
- Tomography, X-Ray Computed
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.